Suppr超能文献

使用葡萄膜黑色素瘤肝转移建立原位患者来源的异种移植小鼠模型。

Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis.

作者信息

Kageyama Ken, Ohara Masahiro, Saito Kengo, Ozaki Shinji, Terai Mizue, Mastrangelo Michael J, Fortina Paolo, Aplin Andrew E, Sato Takami

机构信息

Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, 1015 Walnut Street, Ste. 1024, Philadelphia, PA, 19107, USA.

Department of Radiology, Osaka City University, 1-4-3 Asahimachi Abenoku, Osaka, Osaka, 545-8585, Japan.

出版信息

J Transl Med. 2017 Jun 23;15(1):145. doi: 10.1186/s12967-017-1247-z.

Abstract

BACKGROUND

Metastatic uveal melanoma is a highly fatal disease; most patients die from their hepatic metastasis within 1 year. A major drawback in the development of new treatments for metastatic uveal melanoma is the difficulty in obtaining appropriate cell lines and the lack of appropriate animal models. Patient-derived xenograft (PDX) tumor models, bearing ectopically implanted tumors at a subcutaneous site, have been developed. However, these ectopically implanted PDX models have obstacles to translational research, including a low engraftment rate, slow tumor growth, and biological changes after multiple passages due to the different microenvironment. To overcome these limitations, we developed a new method to directly transplant biopsy specimens to the liver of immunocompromised mice.

RESULTS

By using two metastatic uveal melanoma cell lines, we demonstrated that the liver provides a more suitable microenvironment for tumor growth compared to subcutaneous sites and that surgical orthotopic implantation (SOI) of tumor pieces allows the creation of a liver tumor in immunocompromised mice. Subsequently, 10 of 12 hepatic metastasis specimens from patients were successfully xenografted into the immunocompromised mice (83.3% success rate) using SOI, including 8 of 10 needle biopsy specimens (80%). Additionally, four cryopreserved PDX tumors were re-implanted to new mice and re-establishment of PDX tumors was confirmed in all four mice. The serially passaged xenograft tumors as well as the re-implanted tumors after cryopreservation were similar to the original patient tumors in histologic, genomic, and proteomic expression profiles. CT imaging was effective for detecting and monitoring PDX tumors in the liver of living mice. The expression of Ki67 in original patient tumors was a predictive factor for implanted tumor growth and the success of serial passages in PDX mice.

CONCLUSIONS

Surgical orthotopic implantation of hepatic metastasis from uveal melanoma is highly successful in the establishment of orthotopic PDX models, enhancing their practical utility for research applications. By using CT scan, tumor growth can be monitored, which is beneficial to evaluate treatment effects in interventional studies.

摘要

背景

转移性葡萄膜黑色素瘤是一种高度致命的疾病;大多数患者在1年内死于肝转移。开发转移性葡萄膜黑色素瘤新疗法的一个主要障碍是难以获得合适的细胞系以及缺乏合适的动物模型。已经建立了患者来源的异种移植(PDX)肿瘤模型,即在皮下部位异位植入肿瘤。然而,这些异位植入的PDX模型在转化研究中存在障碍,包括植入率低、肿瘤生长缓慢以及由于微环境不同导致多次传代后的生物学变化。为了克服这些限制,我们开发了一种将活检标本直接移植到免疫缺陷小鼠肝脏的新方法。

结果

通过使用两种转移性葡萄膜黑色素瘤细胞系,我们证明与皮下部位相比,肝脏为肿瘤生长提供了更合适的微环境,并且肿瘤块的手术原位植入(SOI)能够在免疫缺陷小鼠中形成肝肿瘤。随后,使用SOI将12例患者的肝转移标本中的10例成功异种移植到免疫缺陷小鼠中(成功率83.3%),其中10例针吸活检标本中有8例(80%)成功。此外,将4个冷冻保存的PDX肿瘤重新植入新的小鼠体内,所有4只小鼠均证实PDX肿瘤得以重建。连续传代的异种移植肿瘤以及冷冻保存后重新植入的肿瘤在组织学、基因组和蛋白质组表达谱方面与原始患者肿瘤相似。CT成像对于检测和监测活体小鼠肝脏中的PDX肿瘤有效。原始患者肿瘤中Ki67的表达是植入肿瘤生长以及PDX小鼠连续传代成功的预测因素。

结论

葡萄膜黑色素瘤肝转移的手术原位植入在建立原位PDX模型方面非常成功,提高了其在研究应用中的实际效用。通过使用CT扫描,可以监测肿瘤生长,这有利于在干预研究中评估治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cf/5481921/551a534d6b7c/12967_2017_1247_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验